• Return to Headlines

Anthera Pharmace has the Lowest Return on Equity in the Biotechnology Industry (ANTH, CHRS, RGLS, TTOO, IRWD)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Anthera Pharmace ranks lowest with a ROE of -63,542.8%. Following is Coherus Bioscien with a ROE of -59,511.2%. Regulus Therapeu ranks third lowest with a ROE of -35,730.1%.

T2 Biosystems follows with a ROE of -30,693.7%, and Ironwood Pharmac rounds out the bottom five with a ROE of -30,546.2%.

SmarTrend is tracking the current trend status for Ironwood Pharmac and will alert subscribers who have IRWD in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest return on equity anthera pharmace coherus bioscien regulus therapeu t2 biosystems ironwood pharmac

Ticker(s): ANTH CHRS RGLS TTOO IRWD